NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.8850
+0.0150 (1.72%)
At close: Jan 30, 2026, 4:00 PM EST
0.8500
-0.0350 (-3.95%)
Pre-market: Feb 2, 2026, 8:24 AM EST

NMTC Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
12.13.453.412.120.24
Revenue Growth (YoY)
250.35%1.33%60.73%772.60%-87.39%
Cost of Revenue
8.947.448.445.174.2
Gross Profit
3.16-3.99-5.03-3.05-3.96
Selling, General & Admin
7.387.96.936.986.26
Operating Expenses
7.387.96.936.986.26
Operating Income
-4.23-11.89-11.96-10.03-10.22
Interest Expense
-0.2-0.1---0
Interest & Investment Income
--0.2--
Other Non Operating Income (Expenses)
0.82-0.33-0.070.03-0.01
EBT Excluding Unusual Items
-3.61-12.32-11.83-10-10.23
Gain (Loss) on Sale of Assets
---0.03--
Legal Settlements
----0.2
Other Unusual Items
----0.08
Pretax Income
-3.61-12.32-11.86-10-9.95
Net Income
-3.61-12.32-11.86-10-9.95
Net Income to Common
-3.61-12.32-11.86-10-9.95
Shares Outstanding (Basic)
4027181611
Shares Outstanding (Diluted)
4027181611
Shares Change (YoY)
50.03%47.69%13.27%49.56%97.52%
EPS (Basic)
-0.09-0.46-0.65-0.63-0.93
EPS (Diluted)
-0.09-0.46-0.65-0.63-0.93
Free Cash Flow
-2.92-11.13-13.27-7.79-8.67
Free Cash Flow Per Share
-0.07-0.42-0.73-0.49-0.81
Gross Margin
26.11%-115.42%-147.58%-143.93%-
Operating Margin
-34.94%-344.26%-350.84%-473.14%-4205.75%
Profit Margin
-29.80%-356.74%-348.03%-471.67%-4094.60%
Free Cash Flow Margin
-24.13%-322.39%-389.45%-367.67%-3568.48%
EBITDA
-3.96-11.64-11.76-9.91-10.14
EBITDA Margin
-32.77%----
D&A For EBITDA
0.260.250.20.120.08
EBIT
-4.23-11.89-11.96-10.03-10.22
EBIT Margin
-34.94%----
Advertising Expenses
0.170.110.170.270.34
Updated Dec 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q